ANGPTL5
Angiopoietin-related protein 5
Also known as: ANGL5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86XS5
- Gene
- ANGPTL5
- Ensembl
- ENSG00000187151
- Chromosome
- 11
- Canonical length
- 388 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to be located in extracellular region. Predicted to be active in collagen-containing extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
388 residues, UniProt reviewed canonical sequence.
>Q86XS5|ANGPTL5
1 MMSPSQASLL FLNVCIFICG EAVQGNCVHH STDSSVVNIV EDGSNAKDES KSNDTVCKED
61 CEESCDVKTK ITREEKHFMC RNLQNSIVSY TRSTKKLLRN MMDEQQASLD YLSNQVNELM
121 NRVLLLTTEV FRKQLDPFPH RPVQSHGLDC TDIKDTIGSV TKTPSGLYII HPEGSSYPFE
181 VMCDMDYRGG GRTVIQKRID GIIDFQRLWC DYLDGFGDLL GEFWLGLKKI FYIVNQKNTS
241 FMLYVALESE DDTLAYASYD NFWLEDETRF FKMHLGRYSG NAGDAFRGLK KEDNQNAMPF
301 STSDVDNDGC RPACLVNGQS VKSCSHLHNK TGWWFNECGL ANLNGIHHFS GKLLATGIQW
361 GTWTKNNSPV KIKSVSMKIR RMYNPYFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANGPTL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- ovary: 19 nTPM
- breast: 5.2 nTPM
- epididymis: 4.1 nTPM
- adipose tissue: 4 nTPM
- heart muscle: 2.6 nTPM
- skin: 2.3 nTPM
Single-cell type
- ovarian stromal cells: 69 nCPM
- fibroblasts: 33 nCPM
- epicardial cells: 30 nCPM
- leydig cells: 28 nCPM
- peritubular myoid cells: 16 nCPM
- decidual stromal cells: 15 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 0.9 nTPM
- cerebellum: 0.6 nTPM
- hypothalamus: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- cerebral cortex: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.47
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANGPTL5 as an antibody target. Whether an autoantibody or antibody against ANGPTL5 could matter depends on whether native ANGPTL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANGPTL5 is annotated as secreted, so native ANGPTL5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ANGPTL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...